Joseph Hulihan's most recent trade in Marinus Pharmaceuticals Inc was a trade of 4,828 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 05 Aug 2024 | 4,828 | 72,725 (0%) | 0% | 1.1 | 5,456 | Common Stock |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 49,125 | 49,125 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,918 | 77,553 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Hulihan Joseph | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.98 per share. | 16 Feb 2024 | 2,814 | 66,635 (0%) | 0% | 10.0 | 28,084 | Common Stock |
| Marinus Pharmaceuticals Inc | Hulihan Joseph | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 98,250 | 98,250 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,835 | 69,449 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 07 Aug 2023 | 2,889 | 47,627 (0%) | 0% | 9.6 | 27,590 | Common Stock |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 07 Aug 2023 | 13 | 47,614 (0%) | 0% | 8.9 | 116 | Common Stock |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 115,418 | 115,418 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 25,648 | 50,516 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 7,718 | 24,868 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 77,175 | 77,175 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Joseph Hulihan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 17,150 | 17,150 (0%) | 0% | 0 | Common Stock |